These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 15663324

  • 1. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA, Bruno ME.
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET, Zira AN, Theocharis SE.
    J Appl Toxicol; 2007 Dec; 27(4):302-9. PubMed ID: 17429800
    [Abstract] [Full Text] [Related]

  • 5. Complementary gene and protein expression studies and integrative approaches in toxicogenomics.
    Merrick BA, Madenspacher JH.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):189-94. PubMed ID: 15992845
    [Abstract] [Full Text] [Related]

  • 6. Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
    Currie RA, Orphanides G, Moggs JG.
    Reprod Toxicol; 2005 Sep 01; 20(3):433-40. PubMed ID: 15964738
    [Abstract] [Full Text] [Related]

  • 7. OMICS-driven biomarker discovery in nutrition and health.
    Kussmann M, Raymond F, Affolter M.
    J Biotechnol; 2006 Aug 05; 124(4):758-87. PubMed ID: 16600411
    [Abstract] [Full Text] [Related]

  • 8. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.
    Waters M, Boorman G, Bushel P, Cunningham M, Irwin R, Merrick A, Olden K, Paules R, Selkirk J, Stasiewicz S, Weis B, Van Houten B, Walker N, Tennant R.
    EHP Toxicogenomics; 2003 Jan 05; 111(1T):15-28. PubMed ID: 12735106
    [Abstract] [Full Text] [Related]

  • 9. Toxicogenomics in the assessment of immunotoxicity.
    Baken KA, Vandebriel RJ, Pennings JL, Kleinjans JC, van Loveren H.
    Methods; 2007 Jan 05; 41(1):132-41. PubMed ID: 17161310
    [Abstract] [Full Text] [Related]

  • 10. Molecular profiling approaches for identifying novel biomarkers.
    Bailey WJ, Ulrich R.
    Expert Opin Drug Saf; 2004 Mar 05; 3(2):137-51. PubMed ID: 15006720
    [Abstract] [Full Text] [Related]

  • 11. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
    Collins CD, Purohit S, Podolsky RH, Zhao HS, Schatz D, Eckenrode SE, Yang P, Hopkins D, Muir A, Hoffman M, McIndoe RA, Rewers M, She JX.
    Vascul Pharmacol; 2006 Nov 05; 45(5):258-67. PubMed ID: 17030152
    [Abstract] [Full Text] [Related]

  • 12. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics.
    Nagaraja GM, Othman M, Fox BP, Alsaber R, Pellegrino CM, Zeng Y, Khanna R, Tamburini P, Swaroop A, Kandpal RP.
    Oncogene; 2006 Apr 13; 25(16):2328-38. PubMed ID: 16314837
    [Abstract] [Full Text] [Related]

  • 13. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR, Juan HF, Huang HC, Huang HH, Lee YJ, Liao MY, Tseng CW, Lin LL, Chen JY, Wang MJ, Chen JH, Chen YJ.
    J Proteome Res; 2006 Oct 13; 5(10):2727-42. PubMed ID: 17022644
    [Abstract] [Full Text] [Related]

  • 14. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.
    J Proteome Res; 2008 Apr 13; 7(4):1518-28. PubMed ID: 18318472
    [Abstract] [Full Text] [Related]

  • 15. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R, Heijne W, Kienhuis A, van Ommen B, Groten J.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):179-88. PubMed ID: 16139318
    [Abstract] [Full Text] [Related]

  • 16. Functional Genomics meets neurodegenerative disorders Part I: transcriptomic and proteomic technology.
    David DC, Hoerndli F, Götz J.
    Prog Neurobiol; 2005 Jun 01; 76(3):153-68. PubMed ID: 16168556
    [Abstract] [Full Text] [Related]

  • 17. A multivariate analysis approach to the integration of proteomic and gene expression data.
    Fagan A, Culhane AC, Higgins DG.
    Proteomics; 2007 Jun 01; 7(13):2162-71. PubMed ID: 17549791
    [Abstract] [Full Text] [Related]

  • 18. Global profiling of gene expression in cancer using genomics and proteomics.
    Hanash SM.
    Curr Opin Mol Ther; 2001 Dec 01; 3(6):538-45. PubMed ID: 11804268
    [Abstract] [Full Text] [Related]

  • 19. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S.
    Mutat Res; 2005 Aug 04; 575(1-2):102-15. PubMed ID: 15924886
    [Abstract] [Full Text] [Related]

  • 20. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database.
    Kondo C, Minowa Y, Uehara T, Okuno Y, Nakatsu N, Ono A, Maruyama T, Kato I, Yamate J, Yamada H, Ohno Y, Urushidani T.
    Toxicology; 2009 Nov 09; 265(1-2):15-26. PubMed ID: 19761811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.